BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soleimani B, Murray K, Hunt D. Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis. Drug Saf 2019;42:941-56. [PMID: 30830572 DOI: 10.1007/s40264-019-00799-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Narayan N, Mazibrada G, Amft N. Adult-Onset Still Disease as a Novel Autoimmune Complication of Alemtuzumab Therapy: A Case Report and Review of Alemtuzumab-Associated Autoimmune Disease. J Clin Rheumatol 2021;27:S411-3. [PMID: 32251047 DOI: 10.1097/RHU.0000000000001382] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Melnikov M, Pashenkov M, Boyko A. Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential? Int J Mol Sci 2021;22:5313. [PMID: 34070011 DOI: 10.3390/ijms22105313] [Reference Citation Analysis]
3 La Mantia L, Benedetti MD, Sant M, d'Arma A, Di Tella S, Lillini R, Mendozzi L, Marangi A, Turatti M, Caputo D, Rovaris M. Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study. Neurol Sci 2021. [PMID: 33791892 DOI: 10.1007/s10072-021-05216-z] [Reference Citation Analysis]
4 Teixeira N, Sant'anna M, Giardini A, Araujo L, Fonseca L, Basso A, Cury Y, Picolo G. Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG35-55-induced experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Brain, Behavior, and Immunity 2020;84:253-68. [DOI: 10.1016/j.bbi.2019.12.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fischer S, Proschmann U, Akgün K, Ziemssen T. Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects. Cells 2021;10:3177. [PMID: 34831400 DOI: 10.3390/cells10113177] [Reference Citation Analysis]
6 Lunin SM, Khrenov MO, Glushkova OV, Parfenyuk SB, Novoselova TV, Novoselova EG. Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice. Int J Mol Sci 2019;20:E5374. [PMID: 31671728 DOI: 10.3390/ijms20215374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]